These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 1719904)

  • 1. Endogenous 5-hydroxytryptamine modulates the release of tachykinins and calcitonin gene-related peptide from the rat spinal cord via 5-HT3 receptors.
    Saria A; Javorsky F; Humpel C; Gamse R
    Ann N Y Acad Sci; 1991; 632():464-5. PubMed ID: 1719904
    [No Abstract]   [Full Text] [Related]  

  • 2. 5-HT3 receptor antagonists inhibit sensory neuropeptide release from the rat spinal cord.
    Saria A; Javorsky F; Humpel C; Gamse R
    Neuroreport; 1990 Oct; 1(2):104-6. PubMed ID: 1717037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of calcitonin gene-related peptide release from dorsal thoraco-lumbar spinal cord slices by 5-HT3 receptors.
    Scott MA; Fone KC
    Neurosci Lett; 1994 Jul; 175(1-2):5-8. PubMed ID: 7970210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monoaminergic control of the release of calcitonin gene-related peptide- and substance P-like materials from rat spinal cord slices.
    Bourgoin S; Pohl M; Mauborgne A; Benoliel JJ; Collin E; Hamon M; Cesselin F
    Neuropharmacology; 1993 Jul; 32(7):633-40. PubMed ID: 7689707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of 5-hydroxytryptamine3 receptors in the medial prefrontal cortex: a microiontophoretic study.
    Ashby CR; Edwards E; Harkins K; Wang RY
    Eur J Pharmacol; 1989 Dec; 173(2-3):193-6. PubMed ID: 2560433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential influence of two serotonin 5-HT3 receptor antagonists on spinal serotonin-induced analgesia in rats.
    Bardin L; Jourdan D; Alloui A; Lavarenne J; Eschalier A
    Brain Res; 1997 Aug; 765(2):267-72. PubMed ID: 9313899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence that spinal 5-HT1, 5-HT2 and 5-HT3 receptor subtypes modulate responses to noxious colorectal distension in the rat.
    Danzebrink RM; Gebhart GF
    Brain Res; 1991 Jan; 538(1):64-75. PubMed ID: 2018933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversal of the antinociceptive effects of intrathecally administered serotonin in the rat by a selective 5-HT3 receptor antagonist.
    Glaum SR; Proudfit HK; Anderson EG
    Neurosci Lett; 1988 Dec; 95(1-3):313-7. PubMed ID: 3226619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Release of calcitonin gene-related peptide and tachykinins from the rat trachea.
    Hua XY; Yaksh TL
    Peptides; 1992; 13(1):113-20. PubMed ID: 1377821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5-HT3 receptors modulate spinal nociceptive reflexes.
    Glaum SR; Proudfit HK; Anderson EG
    Brain Res; 1990 Feb; 510(1):12-6. PubMed ID: 2322835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [3H]quaternised ICS 205-930 labels 5-HT3 receptor binding sites in rat brain.
    Watling KJ; Aspley S; Swain CJ; Saunders J
    Eur J Pharmacol; 1988 May; 149(3):397-8. PubMed ID: 3409965
    [No Abstract]   [Full Text] [Related]  

  • 12. 5-HT3 receptor antagonists attenuate dopamine-induced hyperactivity in the rat.
    Costall B; Domeney AM; Naylor RJ
    Neuroreport; 1990 Sep; 1(1):77-80. PubMed ID: 1966601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of the tachykinin NK1 receptor antagonists, RP 67580 and SR 140333, on electrically-evoked substance P release from rat spinal cord.
    Malcangio M; Bowery NG
    Br J Pharmacol; 1994 Oct; 113(2):635-41. PubMed ID: 7530576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of p-chloroamphetamine on release of [3H]gamma-aminobutyric acid from slices of rat caudate-putamen.
    Meyer DK; Holland A; Lais A; Szabo B
    Eur J Pharmacol; 1991 Apr; 196(2):189-95. PubMed ID: 1651873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serotonin type-2 receptor mediated regulation of substance P release in the ventral spinal cord and the effects of chronic antidepressant treatment.
    Iverfeldt K; Peterson LL; Brodin E; Ogren SO; Bartfai T
    Naunyn Schmiedebergs Arch Pharmacol; 1986 May; 333(1):1-6. PubMed ID: 2426604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interactions between the tachykinins and calcitonin gene-related peptide lead to the modulation of oedema formation and blood flow in rat skin.
    Brain SD; Williams TJ
    Br J Pharmacol; 1989 May; 97(1):77-82. PubMed ID: 2470460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of 5-hydroxytryptamine agonists and antagonists on identified sympathetic preganglionic neurones in the rat, in vivo.
    Lewis DI; Coote JH
    Br J Pharmacol; 1990 Apr; 99(4):667-72. PubMed ID: 2361167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of a 5-HT3 receptor releases dopamine from rat striatal slice.
    Blandina P; Goldfarb J; Green JP
    Eur J Pharmacol; 1988 Oct; 155(3):349-50. PubMed ID: 3234491
    [No Abstract]   [Full Text] [Related]  

  • 19. Modulation by 5-HT1A receptors of the 5-HT2 receptor-mediated tachykinin-induced contraction of the rat trachea in vitro.
    Germonpré PR; Joos GF; Pauwels RA
    Br J Pharmacol; 1998 Apr; 123(8):1571-8. PubMed ID: 9605563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mediation by 5-HT3 receptors of an excitatory effect of 5-HT on dorsal vagal preganglionic neurones in anaesthetized rats: an ionophoretic study.
    Wang Y; Ramage AG; Jordan D
    Br J Pharmacol; 1996 Aug; 118(7):1697-704. PubMed ID: 8842434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.